Wiki source code of Clinical trials

Last modified by Sarantis Dimitriadis on 2022/06/01 17:48

Hide last authors
Sarantis Dimitriadis 4.2 1 (% class="western" lang="en-GB" style="text-align:justify" %)
2 (% lang="en-US" style="line-height:107%" %)**Description: **Clinical trials are experiments or observations done to evaluate the effectiveness and safety of new solution by monitoring its effects on large groups of people. Subjects are typically divided into two or more groups, one having “real treatment” by using the developed solution and the other group(s) using tried-and-true solution or not using any solution. The results are compared between the groups to evaluate the impacts.
Evdokimos Konstantinidis 1.1 3
Sarantis Dimitriadis 4.2 4 (% class="western" lang="en-GB" style="text-align:justify" %)
5 (% lang="en-US" style="line-height:107%" %)**R&D service category-ies: **Testing and validation
Evdokimos Konstantinidis 1.1 6
Sarantis Dimitriadis 4.2 7 (% class="western" lang="en-GB" style="text-align:justify" %)
8 (% lang="en-US" style="line-height:107%" %)**Key characteristics in Living Lab context:**
Evdokimos Konstantinidis 1.1 9
Sarantis Dimitriadis 4.2 10 * (((
11 (% lang="en-GB" style="text-align:justify" %)
12 (% lang="en-US" style="line-height:107%" %)Clinical trials are similar to impact assessment and validation test activities but follow more strict validation and approval process.
13 )))
Evdokimos Konstantinidis 1.1 14
Sarantis Dimitriadis 4.2 15 (% class="western" lang="en-GB" style="text-align:justify" %)
16 (% lang="en-US" style="line-height:107%" %)**Participants’ role:**
Evdokimos Konstantinidis 1.1 17
Sarantis Dimitriadis 4.2 18 * (((
19 (% lang="en-GB" style="text-align:justify" %)
20 (% lang="en-US" style="line-height:107%" %)Customers as co-creators
21 )))
Evdokimos Konstantinidis 1.1 22
Sarantis Dimitriadis 4.2 23 (% class="western" lang="en-GB" style="text-align:justify" %)
Evdokimos Konstantinidis 1.1 24 **Objectives**
25
Sarantis Dimitriadis 4.2 26 * (% lang="en-US" style="line-height:107%" %)To find out if new solutions are safe and effective
27 * (% lang="en-US" style="line-height:107%" %)Get official approval for new solution
Evdokimos Konstantinidis 1.1 28
Sarantis Dimitriadis 4.2 29 (% class="western" lang="en-GB" style="text-align:justify" %)
30 (% lang="en-US" style="line-height:107%" %)**Methods:**
Evdokimos Konstantinidis 1.1 31
Sarantis Dimitriadis 4.2 32 * (((
33 (% lang="en-GB" style="text-align:justify" %)
34 (% lang="en-US" style="line-height:107%" %)Has multiple phases and classes which depend on the developed solution
35 )))

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project